Theratechnologies Inc. (TSE:TH - Get Free Report) reached a new 52-week high on Monday . The company traded as high as C$4.31 and last traded at C$4.32, with a volume of 193034 shares traded. The stock had previously closed at C$4.18.
Analyst Upgrades and Downgrades
Separately, Jones Trading cut Theratechnologies from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 3rd.
Check Out Our Latest Stock Report on Theratechnologies
Theratechnologies Stock Up 0.2%
The company has a debt-to-equity ratio of -293.92, a current ratio of 1.08 and a quick ratio of 0.64. The company has a market capitalization of C$137.51 million, a PE ratio of -48.79, a P/E/G ratio of -8.50 and a beta of 1.73. The business's 50 day simple moving average is C$3.63 and its 200 day simple moving average is C$2.95.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
See Also
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
